Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Choo%2C+Joan+R+E%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Choo%2C+Joan+R+E%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Choo%2C+Joan+R+E%22&type=Person&sort=year
PubPharm (13)
1
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines
enthalten in:
European journal of cancer (Oxford, England : 1990)
| 2023
von
Lim, J.
|
Ow, S.
|
Wong, A.
| +9
Wird geladen...
2
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
enthalten in:
Annals of surgical oncology
| 2022
von
Chia, D.
|
Sundar, R.
|
Kim, G.
| +22
CommentIn: Ann Surg Oncol. 2022 Dec;29(13):8606-8607. - PMID 36192514
Wird geladen...
3
Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer
enthalten in:
Thoracic cancer
| 2022
von
Huang, Y.
|
Zhao, J.
|
Soon, Y.
| +12
Wird geladen...
4
ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
enthalten in:
Annals of surgical oncology
| 2022
von
Chia, D.
|
Sundar, R.
|
Kim, G.
| +22
Wird geladen...
5
ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
enthalten in:
Annals of surgical oncology
| 2022
von
Chia, D.
|
Sundar, R.
|
Kim, G.
| +22
Wird geladen...
6
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
enthalten in:
Annals of surgical oncology
| 2022
von
Chia, D.
|
Sundar, R.
|
Kim, G.
| +22
Wird geladen...
7
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
enthalten in:
Annals of surgical oncology
| 2022
von
Chia, D.
|
Sundar, R.
|
Kim, G.
| +22
Wird geladen...
8
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
enthalten in:
Annals of surgical oncology
| 2022
von
Chia, D.
|
Sundar, R.
|
Kim, G.
| +22
Wird geladen...
9
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Lim, J.
|
Wong, A.
|
Ow, S.
| +20
Wird geladen...
10
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors
enthalten in:
Targeted oncology
| 2022
von
Choo, J.
|
Jan, Y.
|
Ow, S.
| +17
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
13
Aufsätze
10
E-Artikel
10
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
6
Annals of surgical oncology
3
Targeted oncology
1
Clinical cancer research : an official journal ...
1
European journal of cancer (Oxford, England : 1...
1
Thoracic Cancer
1
Thoracic cancer
Alle anzeigen ...
weniger ...
Thema
5
Journal Article
3
EC 2.7.10.1
3
Research Support, Non-U.S. Gov't
2
Clinical Trial, Phase II
2
Receptor, ErbB-2
1
04ZR38536J
1
0W860991D6
1
28X28X9OKV
1
2S9ZZM9Q9V
1
49DFR088MY
1
6804DJ8Z9U
1
7LKK855W8I
1
Angiogenesis Inhibitors
1
Antineoplastic Agents, Immunological
1
Bevacizumab
1
Biomarkers, Tumor
1
Capecitabine
1
Chemotherapy
1
Clinical Trial, Phase I
1
Deoxycytidine
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2023
12
2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...